Sucralfate for the treatment of radiation induced mucositis;Einsatz von Sucralfat in der Radioonkologie

Strahlentherapie und Onkologie

Volumn 173, Issue 5, 1997, Pages 247-252

  Belka, C ^a   Hoffmann, W ^a   Paulsen, F ^a   Bamberg, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANALGESIC AGENT; ANTACID AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; LOPERAMIDE; SALAZOSULFAPYRIDINE; SUCRALFATE;

CANCER RADIOTHERAPY; HUMAN; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; SHORT SURVEY;

EID: 0030925180     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03039433     Document Type: Short Survey

References (25)

1. Allison, R. R., V. Vongtama, J. Vaughan, K. H. Shin: Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole. Cancer Invest. 13 (1995), 16.
2. Brown, D. T., C. H. Miller, D. E. Maupin: The effect of sucralfate on the growth of carigenic streptococci. J. prosthet. Dent. 66 (1991), 256.
3. Epstein J. B., P. Stevenson-Moore: Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy. Oral Surg. oral Med. oral Path. 62 (1986), 145.
4. Epstein J. B., F. L. Wong: The efficacy of sucralfate suspension in the prevention of oral mucositis doe to radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 28 (1994), 693.
5. Franzen, L., R. Henriksson, B. Littbrand, B. Zackrisson: Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study. Acta Oncol. 34 (1995), 219.
6. Henriksson, R., L. Franzen, B. Littbrand: Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. J. clin. Oncol. 10 (1992), 969.
7. Hoffmann, W., H. P. Rodemann, H. Schmidberger, B. Weiss, M. Bamberg: Enhanced muco-cutaneous toxicity of radiotherapy in a patient with chronic GVHD and secondary malignancy. Ann. Oncol. 5 (1994), 377.
8. Hombrink, J., A.-C. Voss, D. Fröhlich, M. Glatzel, A. Krauß, F. H. Glaser. Therapieansätze zur Prophylaxe der strahleninduzierten Diarrhoe nach Becken- und Abdominalbestrahlung. Strahlenther. Onkol. 171 (1995), 49.
9. Hughes, L. L., T. A. Rich, L. Delclos, J. A. Ajani, R. G. Martin: Radiotherapy for anal cancer: experience front 1979-1987. Int. J. Radiat. Oncol. Biol. Phys. 17 (1989), 1153.
10. Jansma, J., A. Vissink, F. K. Spijkervet, J. N. Roodenburg, A. K. Panders, A. Vermey, B. G. Szabo, J. s'Gravenmade: Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation. Cancer 70 (1992), 2171.
11. Kim, J. H., F. C. Chu, V. Lakshmi, R. Houde: Benzydamine-HCl: a new agent for the treatment of radiation mucositis of the oropharynx. Amer. J. clin. Oncol. 9 (1986), 132.
12. Kochhar, R., F. Patel, A. Dhar, S. C. Sharma, S. Ayyagari, R. Aggarwal, M. K. Goenka, B. D. Gupta, S. K. Mehta: Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig. Dis. Sci. 36 (1991), 103.
13. Loprinzi, C. L., R. L. Foote, J. Michalak: Alleviation of cytotoxic therapy induced normal tissue damage. Semin. Oncol. 22 (1995), 95.
14. Maiche, A., O. P. Isokangas, P. Grohn: Skin protection by sucralfate cream during electron beam therapy. Acta Oncol. 33 (1994), 201.
15. Makkonen, T. A., P. Bostrom, P. Vilja, H. Joensun: Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study. Int. J. Radiat. Oncol. Biol. Phys. 30 (1994), 177.
16. Nakanzawa, S., R. Nagashima, M. Samloff: Selective binding of sucralfate to gastric ulcer in man. Dig. Dis. Sci. 126 (1981), 297.
17. Paulsen, F., W. Hoffmann, R. D. Kortmann, R. Porschen, M. Bamberg: Akute gastrointestinale Nebenwirkungen in der Radioonkologie - Was ist gesichert in der Therapie? Strahlenther. Onkol. 172 (1996), 53.
18. Prada, A., F. Chiesa: Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. Int. J. Tiss. React. 9 (1978), 115.
19. Rees, W. D.: Mechanism of gastroduodenal protection by sucralfate. Amer. J. Med. 91 (1991), 58.
20. Scherlacher, A., F. Beaufort-Spontin: Radiotherapy of head-neck neoplasms: prevention of inflammation of the mucosa by sucralfate treatment. HNO 38 (1990), 24.
21. Sur, R. K., R. Kochhar, D. P. Singh: Oral sucralfate in acute radiation oesophagitis. Acta Oncol. 33 (1994), 61.
22. Taal, B. G., R. A. Vales-Olmos, H. Boot, C. A. Hoefnagel: Assessment of sucralfate coating by sequential scintigraphic imaging in radiation-induced esophageal lesions. Gastrointest. Endosc. 41 (1995), 109.
23. Tarnawski, A., D. Hollander, J. Stachura, H. Gergly, W. J. Krause, R. Zipser: Trophic effect of long term sucralfate treatment on the gastric mucosa. Gastroenterology 88 (1985), 1610.
24. Verdi, C. J.: Cancer therapy and oral mucositis. An appraisal of drug prophylaxis. Drug Saf. 9 (1993), 185.
25. Yeoh, E. K., M. Horowitz, A. Russo, T. Muecke, T. Robb, B. E. Chatterton: Gastrointestinal function in chronic radiation enteritis - effects of loperamide-N-oxide. Gut 34 (1993), 476.